Press Releases SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy April 26, 2023 SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label. March 20, 2023 SOHM, Inc. Shares Outlook for the Year 2023 and Progress On its Manufacturing Facility and Other Projects. March 2, 2023 SOHM, Inc. Shares Progress On its Manufacturing Facility and Other Projects December 13, 2022 SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects October 18, 2022 SOHM, Inc., Has Signed Manufacturing and Supply Skincare Topical Products with New Customer. August 29, 2022 SOHM, Inc., is in Discussion with Generic Pharmaceutical Company for the Majority of Stock Acquisitions as Vertical Integration July 27, 2022 SOHM, Inc., Updates, Revises Its short-term and Long-term Goals. June 29, 2022 < Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 >
SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy April 26, 2023
SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label. March 20, 2023
SOHM, Inc. Shares Outlook for the Year 2023 and Progress On its Manufacturing Facility and Other Projects. March 2, 2023
SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects October 18, 2022
SOHM, Inc., Has Signed Manufacturing and Supply Skincare Topical Products with New Customer. August 29, 2022
SOHM, Inc., is in Discussion with Generic Pharmaceutical Company for the Majority of Stock Acquisitions as Vertical Integration July 27, 2022
